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Methylpyrrolidinone chitosan  (MPC) is  a derivatized chitosan polymer obtained by 
chemical modification of natural chitosan; it is characterised by pyrrolidinone groups 
covalently attached to the polysaccharide backbone. This chitosan derivative combines the 
biocompatibility of chitosan and the hydrophilic characteristics of the pyrrolidinone moiety, 
being particularly susceptible to the hydrolytic action of lysozyme [Giunchedi, et al. 1998; 
Muzzarelli, 1992). 
The purpose of this work was the preparation and the study of methypyrrolidinone chitosan 
spray-dried microspheres for the intranasal release of metoclopramide hydrochloride (Met). 
Chitosan (CH) microparticles were prepared as comparison. 
Microspheres were obtained by the spray-drying technique; a solution containing 1.0% 
(w/v) of total solid (drug and polymer) in acidic media was sprayed. Two different 
polymers to drug ratios, 1:1 and 1:2 were chosen. The microparticles obtained were 
characterised by a series of pharmaceutical properties including encapsulation efficiency, 
microspheres morphology, size distribution and drug release behaviour at pH 7.0. Swelling 
tests and ex-vivo mucoadhesion and permeation studies using sheep nasal mucosa were 
carried out. 
The results obtained show drug content values close to the theoretical amounts and the 
incorporation efficiencies of the model drug, Met, within the range 95-100%.  
Particle size analyses indicate that the preparations are characterised by narrow size 
distributions regardless polymeric composition and drug loaded: microparticles have dvs 
values of about 6-8 µm. 
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In vitro Met release test shows that the total amount of drug is released within 1 h 
regardless polymer used and drug to polymer ratio. The microspheres control the drug 
release compared to the dissolution rate of the Met. 
Microparticles based on chitosan derivatised interact with the mucin showing good ex-vivo 
mucoadhesive properties and also good ex-vivo drug permeation profiles (Figure 1). 
In conclusion these preliminary results show that MPC microspheres could be suitable for 
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